ENDOCYTE INC·4

Feb 21, 5:30 PM ET

Nguyen Binh 4

4 · ENDOCYTE INC · Filed Feb 21, 2013

Insider Transaction Report

Form 4
Period: 2013-02-19
Nguyen Binh
VP of Clinical Affairs
Transactions
  • Award

    Stock Option (right to buy)

    2013-02-19+70,00070,000 total
    Exercise: $9.86Exp: 2023-02-19Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 19, 2014.

Documents

1 file
  • 4
    v335834_4.xmlPrimary

    OWNERSHIP DOCUMENT